Lion's mane Hericium erinaceus (Bull.) Pers.
Also called: yamabushitake, hou tou gu, monkey head mushroom, bearded tooth mushroom, pom pom mushroom, hedgehog fungus
Lion's mane, Hericium erinaceus, is an edible mushroom that grows on dead hardwood trees and has long, hanging white spines. It is eaten raw, dried or cooked, and sold as capsules, powders and liquid extracts.
- Category
- Mushroom
- Forms
- Fruiting body; mycelium (one trial used mycelium enriched in erinacine A)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 2 Moderately studied in people. A 2025 systematic review (Front Nutr) included 5 RCTs and 3 pilot clinical trials of Hericium erinaceus in people, plus a cohort study and a case report; it did not pool five or more trials. [6]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Mild cognitive impairment in older adults | C | RCT in 30 Japanese adults aged 50–80: tablets of dried lion's mane powder for 16 weeks raised cognitive scale scores versus placebo at weeks 8, 12 and 16; scores fell again 4 weeks after stopping. [2] |
| Mild Alzheimer's disease | C | 49-week pilot RCT (49 randomized, 41 completed): erinacine A-enriched mycelium capsules were linked to better MMSE and daily-activity scores than placebo, whose cognitive screening scores declined. [3] |
| Cognition, stress and mood in healthy young adults | C | Pilot RCT in 41 adults aged 18–45 (1.8 g): faster Stroop performance 60 minutes after one dose and a non-significant trend to lower stress after 28 days; other results were null. [4] |
| Depression and anxiety scores in women | C | 30 women ate lion's mane or placebo cookies for 4 weeks; depression and complaint scores fell from baseline with lion's mane, but only two complaint items differed significantly from placebo. [5] |
Main constituents: Hericenones and erinacines (terpenoids), phenolic acids, polysaccharides, sterols and lactones [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Four 250 mg tablets containing 96% dried lion's mane powder, three times a day, for 16 weeks (mild cognitive impairment trial). [2]
- Three 350 mg capsules per day of mycelium containing 5 mg/g erinacine A, for 49 weeks (mild Alzheimer's disease trial). [3]
- 1.8 g per day for 28 days (healthy young adults). [4]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Abdominal discomfort, nausea and skin rash were reported in a clinical study. [1]
- In the 49-week Alzheimer's trial, four participants dropped out because of abdominal discomfort, nausea or skin rash; no other adverse events were reported. [3]
- A 2025 systematic review lists stomach discomfort, headache and allergic reactions as potential side effects, often unreported. [6]
- Use in food and tea is generally considered safe; supplements are more concentrated than culinary use. [1]
Identity, quality and standardization
- Index Fungorum lists Hericium erinaceus (Bull.) Pers. as the current name. [7]
Regulatory status
- US: sold as dietary supplements in capsules, powders and liquid extracts. [1]
- US: medicinal mushrooms are sold as dietary supplements, which do not require FDA premarket evaluation and approval. The FDA has not approved medicinal mushrooms as a treatment for cancer or any other medical condition. [8]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming Hericium: NDI 1052, an ingredient named "Bio-Hericium" (submitted 2017-11-16); the entry does not state the species. No entry names lion's mane or Hericium erinaceus. Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each component that is a dietary ingredient, before use — Required by 21 CFR 111.75(a)(1)(i); a manufacturer may petition for an exemption from this testing under 111.75(a)(1)(ii). [P5]
Supply and conservation
- IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P6]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Memorial Sloan Kettering Cancer Center. About Herbs: Lion's Mane Mushroom (last updated June 5, 2024), 2024-06-05. mskcc.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (accessed October 29, 2026), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR) list (accessed October 29, 2026), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75 (title 21 displayed up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Hericium erinaceus (Bull.) Pers., 2026-10-29. api.gbif.org
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Lion's Mane Mushroom (last updated June 5, 2024), 2024-06-05. mskcc.org
- Mori K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 2009;23(3):367-72, 2009-03. pubmed.ncbi.nlm.nih.gov
- Li IC, et al. Prevention of early Alzheimer's disease by erinacine A-enriched Hericium erinaceus mycelia: pilot double-blind placebo-controlled study. Front Aging Neurosci 2020;12:155, 2020-06-03. pubmed.ncbi.nlm.nih.gov
- Docherty S, et al. The acute and chronic effects of lion's mane mushroom supplementation on cognitive function, stress and mood in young adults: a double-blind, parallel groups, pilot study. Nutrients 2023;15(22):4842, 2023-11-20. pubmed.ncbi.nlm.nih.gov
- Nagano M, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res 2010;31(4):231-7, 2010-08. pubmed.ncbi.nlm.nih.gov
- Menon A, et al. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Front Nutr 2025;12:1641246, 2025-09-01. pubmed.ncbi.nlm.nih.gov
- Index Fungorum. Hericium erinaceus (Bull.) Pers., record 356812 (accessed October 28, 2026). indexfungorum.org
- National Cancer Institute. Medicinal Mushrooms (PDQ®)–Health Professional Version (latest update 11/06/2024), 2024-11-06. cancer.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in mushroom: Chaga · Cordyceps · Maitake · Reishi · Shiitake · Turkey tail · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.